Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The subject-by-formulation interaction in multivariate bioequivalence.

Li Cao1, Thomas Mathew

  • 1Department of Mathematics and Statistics, University of Maryland Baltimore County, Baltimore, MD 21250, USA.

Journal of Biopharmaceutical Statistics
|May 5, 2007
PubMed
Summary

This study introduces novel hypothesis tests for multivariate bioequivalence, focusing on subject-by-formulation interactions. These tests address zero interaction matrices and threshold comparisons, advancing the field beyond average bioequivalence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Network analysis of pediatric eating disorder symptoms in a treatment-seeking, transdiagnostic sample.

Journal of abnormal psychology·2018
Same author

Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.

Journal of experimental & clinical cancer research : CR·2018
Same author

Hemopexin is required for adult neurogenesis in the subventricular zone/olfactory bulb pathway.

Cell death & disease·2018
Same author

Novel Mutations in SCN4A Gene Cause Myotonia Congenita with Scoliosis.

Chinese medical journal·2018
Same author

Plasma Hemopexin ameliorates murine spinal cord injury by switching microglia from the M1 state to the M2 state.

Cell death & disease·2018
Same author

Myt1L Promotes Differentiation of Oligodendrocyte Precursor Cells and is Necessary for Remyelination After Lysolecithin-Induced Demyelination.

Neuroscience bulletin·2018

Area of Science:

  • Pharmacokinetics and Biopharmaceutics
  • Statistical Modeling
  • Drug Development

Background:

  • Current multivariate bioequivalence literature primarily focuses on average bioequivalence.
  • Existing univariate bioequivalence methods address variance and subject-by-formulation interactions, but these are under-explored in multivariate settings.
  • The subject-by-formulation interaction is crucial for understanding drug product variability.

Purpose of the Study:

  • To develop and evaluate hypothesis tests for the subject-by-formulation interaction matrix in multivariate bioequivalence.
  • To address two specific testing problems: (a) testing for a zero interaction matrix and (b) testing if scalar functions of the matrix are below a threshold.
  • To provide a foundational statistical framework for subject-by-formulation interaction in multivariate bioequivalence.

Related Experiment Videos

Main Methods:

  • Development of approximate hypothesis tests for the subject-by-formulation interaction matrix.
  • Numerical investigation to assess the accuracy of the proposed approximate tests.
  • Application of the methods to a relevant example to demonstrate practical utility.

Main Results:

  • Approximate tests were successfully developed for both hypothesized scenarios concerning the subject-by-formulation interaction matrix.
  • Numerical simulations confirmed the accuracy of the developed approximate tests.
  • The study provides a practical illustration through an example, showcasing the application of the new methods.

Conclusions:

  • This research presents the first statistical tests specifically designed for subject-by-formulation interaction in multivariate bioequivalence.
  • The developed methods offer a significant advancement over existing approaches, which are limited to average bioequivalence.
  • The findings pave the way for more comprehensive assessments of drug product similarity in complex pharmacokinetic studies.